Unaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands |
Total |
IPO |
Private Placement |
Series A Redeemable
Convertible Preferred
Stock |
Common Stock |
Common Stock
IPO
|
Common Stock
Private Placement
|
Additional
Paid-In
Capital |
Additional
Paid-In
Capital
IPO
|
Additional
Paid-In
Capital
Private Placement
|
Accumulated
Deficit |
Accumulated
Other
Comprehensive
(Loss) Income |
Beginning balance, shares at Dec. 31, 2020 |
|
|
|
23,081,000
|
125,037,000
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
$ (550,632)
|
|
|
$ 70,906
|
$ 126
|
|
|
$ 102,417
|
|
|
$ (639,348)
|
$ (13,827)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
244,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
151
|
|
|
|
|
|
|
151
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
27,000
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings (in shares) |
|
|
|
|
(9,000)
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings |
(100)
|
|
|
|
|
|
|
(100)
|
|
|
|
|
Stock-based compensation |
3,799
|
|
|
|
|
|
|
3,799
|
|
|
|
|
Net issuance and repayments of full recourse notes receivable |
44
|
|
|
|
|
|
|
44
|
|
|
|
|
Special dividends |
(23)
|
|
|
|
|
|
|
(23)
|
|
|
|
|
Other comprehensive income |
2,964
|
|
|
|
|
|
|
|
|
|
|
2,964
|
Net loss |
(9,823)
|
|
|
|
|
|
|
|
|
|
(9,823)
|
|
Ending balance, shares at Mar. 31, 2021 |
|
|
|
23,081,000
|
125,299,000
|
|
|
|
|
|
|
|
Ending balance at Mar. 31, 2021 |
(553,620)
|
|
|
$ 70,906
|
$ 126
|
|
|
106,288
|
|
|
(649,171)
|
(10,863)
|
Beginning balance, shares at Dec. 31, 2020 |
|
|
|
23,081,000
|
125,037,000
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
(550,632)
|
|
|
$ 70,906
|
$ 126
|
|
|
102,417
|
|
|
(639,348)
|
(13,827)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income |
12,203
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(87,893)
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance, shares at Sep. 30, 2021 |
|
|
|
0
|
197,048,000
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
191,044
|
|
|
$ 0
|
$ 197
|
|
|
919,712
|
|
|
(727,241)
|
(1,624)
|
Beginning balance, shares at Mar. 31, 2021 |
|
|
|
23,081,000
|
125,299,000
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
(553,620)
|
|
|
$ 70,906
|
$ 126
|
|
|
106,288
|
|
|
(649,171)
|
(10,863)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
213,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
136
|
|
|
|
|
|
|
136
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
32,000
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings (in shares) |
|
|
|
|
(6,000)
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings |
(109)
|
|
|
|
|
|
|
(109)
|
|
|
|
|
Stock-based compensation |
44,810
|
|
|
|
|
|
|
44,810
|
|
|
|
|
Special dividends |
(16)
|
|
|
|
|
|
|
(16)
|
|
|
|
|
Other comprehensive income |
1,323
|
|
|
|
|
|
|
|
|
|
|
1,323
|
Net loss |
(38,395)
|
|
|
|
|
|
|
|
|
|
(38,395)
|
|
Ending balance, shares at Jun. 30, 2021 |
|
|
|
23,081,000
|
125,538,000
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2021 |
(545,871)
|
|
|
$ 70,906
|
$ 126
|
|
|
151,109
|
|
|
(687,566)
|
(9,540)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
82,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
93
|
|
|
|
|
|
|
93
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
112,000
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings (in shares) |
|
|
|
|
(49,000)
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings |
(1,669)
|
|
|
|
|
|
|
(1,669)
|
|
|
|
|
Stock-based compensation |
38,150
|
|
|
|
|
|
|
38,150
|
|
|
|
|
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) |
|
|
|
(23,081,000)
|
46,162,000
|
|
|
|
|
|
|
|
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering |
70,905
|
|
|
$ (70,906)
|
$ 46
|
|
|
70,859
|
|
|
|
|
Issuance of common stock (in shares) |
|
|
|
|
|
21,989,000
|
3,214,000
|
|
|
|
|
|
Issuance of common stock |
|
$ 581,833
|
$ 85,050
|
|
|
$ 22
|
$ 3
|
|
$ 581,811
|
$ 85,047
|
|
|
Deferred offering costs |
(5,636)
|
|
|
|
|
|
|
(5,636)
|
|
|
|
|
Special dividends |
(52)
|
|
|
|
|
|
|
(52)
|
|
|
|
|
Other comprehensive income |
7,916
|
|
|
|
|
|
|
|
|
|
|
7,916
|
Net loss |
(39,675)
|
|
|
|
|
|
|
|
|
|
(39,675)
|
|
Ending balance, shares at Sep. 30, 2021 |
|
|
|
0
|
197,048,000
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
191,044
|
|
|
$ 0
|
$ 197
|
|
|
919,712
|
|
|
(727,241)
|
(1,624)
|
Beginning balance, shares at Dec. 31, 2021 |
|
|
|
|
198,084,000
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
197,551
|
|
|
|
$ 198
|
|
|
947,160
|
|
|
(748,012)
|
(1,795)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
202,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
225
|
|
|
|
|
|
|
225
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
392,000
|
|
|
|
|
|
|
|
Stock-based compensation |
22,346
|
|
|
|
|
|
|
22,346
|
|
|
|
|
Shares repurchased (in shares) |
|
|
|
|
(79,000)
|
|
|
|
|
|
|
|
Repurchased common stock |
(1,102)
|
|
|
|
|
|
|
|
|
|
(1,102)
|
|
Other comprehensive income |
1,440
|
|
|
|
|
|
|
|
|
|
|
1,440
|
Net loss |
(30,609)
|
|
|
|
|
|
|
|
|
|
(30,609)
|
|
Ending balance, shares at Mar. 31, 2022 |
|
|
|
|
198,599,000
|
|
|
|
|
|
|
|
Ending balance at Mar. 31, 2022 |
189,851
|
|
|
|
$ 198
|
|
|
969,731
|
|
|
(779,723)
|
(355)
|
Beginning balance, shares at Dec. 31, 2021 |
|
|
|
|
198,084,000
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
$ 197,551
|
|
|
|
$ 198
|
|
|
947,160
|
|
|
(748,012)
|
(1,795)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
305,000
|
|
|
|
|
|
|
|
|
|
|
|
Shares repurchased (in shares) |
(5,664,151)
|
|
|
|
|
|
|
|
|
|
|
|
Repurchased common stock |
$ (64,000)
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income |
6,293
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(53,896)
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance, shares at Sep. 30, 2022 |
|
|
|
|
193,848,000
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
153,826
|
|
|
|
$ 193
|
|
|
1,015,068
|
|
|
(865,933)
|
4,498
|
Beginning balance, shares at Mar. 31, 2022 |
|
|
|
|
198,599,000
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
189,851
|
|
|
|
$ 198
|
|
|
969,731
|
|
|
(779,723)
|
(355)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
174,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
1,262
|
|
|
|
|
|
|
1,262
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
268,000
|
|
|
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards |
0
|
|
|
|
$ 1
|
|
|
(1)
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings (in shares) |
|
|
|
|
(1,000)
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings |
(30)
|
|
|
|
|
|
|
(30)
|
|
|
|
|
Stock-based compensation |
23,596
|
|
|
|
|
|
|
23,596
|
|
|
|
|
Shares repurchased (in shares) |
|
|
|
|
(2,961,000)
|
|
|
|
|
|
|
|
Repurchased common stock |
(38,053)
|
|
|
|
$ (3)
|
|
|
|
|
|
(38,050)
|
|
Other comprehensive income |
2,209
|
|
|
|
|
|
|
|
|
|
|
2,209
|
Net loss |
(13,179)
|
|
|
|
|
|
|
|
|
|
(13,179)
|
|
Ending balance, shares at Jun. 30, 2022 |
|
|
|
|
196,079,000
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
165,656
|
|
|
|
$ 196
|
|
|
994,558
|
|
|
(830,952)
|
1,854
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
|
46,000
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
195
|
|
|
|
|
|
|
195
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock awards and ESPP (in shares) |
|
|
|
|
350,000
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings (in shares) |
|
|
|
|
(2,000)
|
|
|
|
|
|
|
|
Shares surrendered for settlement of minimum statutory tax withholdings |
(11)
|
|
|
|
|
|
|
(11)
|
|
|
|
|
Stock-based compensation |
20,326
|
|
|
|
|
|
|
20,326
|
|
|
|
|
Shares repurchased (in shares) |
|
|
|
|
(2,625,000)
|
|
|
|
|
|
|
|
Repurchased common stock |
(24,876)
|
|
|
|
$ (3)
|
|
|
|
|
|
(24,873)
|
|
Other comprehensive income |
2,644
|
|
|
|
|
|
|
|
|
|
|
2,644
|
Net loss |
(10,108)
|
|
|
|
|
|
|
|
|
|
(10,108)
|
|
Ending balance, shares at Sep. 30, 2022 |
|
|
|
|
193,848,000
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
$ 153,826
|
|
|
|
$ 193
|
|
|
$ 1,015,068
|
|
|
$ (865,933)
|
$ 4,498
|